aerosol inhaled amikacin
B2017-197R
Phase 1 small_molecule completed
Quick answer
aerosol inhaled amikacin for Chronic Obstructive Pulmonary Disease (COPD) is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed